The aims of this study were to use a xenograft model of breast cancer to confirm the effect of COX-2 inhibition on tumour growth in vivo, and to subsequently determine the mechanism of action, by studying expression of markers of cell proliferation (Ki67 and p21cip1), apoptosis (TUNEL) and AKT activation. Here, PTGS2 is linked to neoplasm.